Recurrent Pancreatic Carcinoma Completed Phase 2 Trials for Vismodegib (DB08828)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent

IndicationStatusPhase
DBCOND0043478 (Recurrent Pancreatic Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01195415Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic CancerTreatment